Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

about

Basal markers and prognosis in luminal breast cancer.Molecular subtyping of mammary-like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas.Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.

P2860

Q42506475-1CBD2F3E-5972-42E0-8A90-AFE7A4F37AC0 Q42508624-A0A16838-8058-4483-81EC-3F5D9D05BE2B Q48265721-A53A68EC-3D05-4424-BDF1-11EBD91B7DD0

P2860

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

Item

http://www.wikidata.org/entity/Q40656600

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Basal biomarkers nestin and IN ...... sitive for oestrogen receptor.

@en

type

Item

label

Basal biomarkers nestin and IN ...... sitive for oestrogen receptor.

@en

prefLabel

Basal biomarkers nestin and IN ...... sitive for oestrogen receptor.

@en

P1476

Basal biomarkers nestin and IN ...... sitive for oestrogen receptor.

@en

P2093

Brandon S Sheffield

http://www.w3.org/2001/XMLSchema#string

C Blake Gilks

http://www.w3.org/2001/XMLSchema#string

Dongxia Gao

http://www.w3.org/2001/XMLSchema#string

Jennifer R Won

http://www.w3.org/2001/XMLSchema#string

Karama Asleh-Aburaya

http://www.w3.org/2001/XMLSchema#string

Philip S Bernard

http://www.w3.org/2001/XMLSchema#string

Robert Wolber

http://www.w3.org/2001/XMLSchema#string

Stephen K L Chia

http://www.w3.org/2001/XMLSchema#string

Torsten O Nielsen

http://www.w3.org/2001/XMLSchema#string

Xiu Q Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Supervised risk predictor of breast cancer based on intrinsic subtypes

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

P304

185-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.13038

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27402148

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

about

P2860

P2860

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921